Download PDF
Thromb Haemost 1961; 05(02): 256-266
DOI: 10.1055/s-0038-1654923
Originalarbeiten – Original Article – Travaux Originaux
Schattauer GmbH

Progressive Antithrombin and Fibrinogen The Antithrombin Time According to Innerfield and its Relation to Acute Pancreatitis

J. M Greep
1   Department of Surgery (Head: C. van Staveren), Department of Clinical Biochemistry (Head: Dr. B, Leijnse), Municipal Hospital Coolsingel Dijkzigt, Rotterdam. — Medical Department University Hospital (Director: Prof. Dr. J. Mulder), Leyden. — Medical Department University Hospital (Directors: Prof. Dr. L. A. Hulst and Prof. Dr. F. L. J. Jordan), Utrecht, Netherlands
,
E. A Loeliger
1   Department of Surgery (Head: C. van Staveren), Department of Clinical Biochemistry (Head: Dr. B, Leijnse), Municipal Hospital Coolsingel Dijkzigt, Rotterdam. — Medical Department University Hospital (Director: Prof. Dr. J. Mulder), Leyden. — Medical Department University Hospital (Directors: Prof. Dr. L. A. Hulst and Prof. Dr. F. L. J. Jordan), Utrecht, Netherlands
,
J Roos
1   Department of Surgery (Head: C. van Staveren), Department of Clinical Biochemistry (Head: Dr. B, Leijnse), Municipal Hospital Coolsingel Dijkzigt, Rotterdam. — Medical Department University Hospital (Director: Prof. Dr. J. Mulder), Leyden. — Medical Department University Hospital (Directors: Prof. Dr. L. A. Hulst and Prof. Dr. F. L. J. Jordan), Utrecht, Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

    Permissions and Reprints

Summary

Innerfield’s method of determining antithrombin III using plasma “defibrinated” by thrombin is submitted to criticsm. This method proves to involve insufficient defibrination: the higher the fibrinogen concentration of the plasma to be tested, the larger the fibrinogen remnant after “defibrination”. The residual fibrinogen interferes in the determinations of antithrombin III, as fibrin (antithrombin I) adsorbes thrombin; an increase in antithrombin III activity is suggested. This becomes manifest in all conditions associated with hyperfibrinogenaemia, including acute pancreatitis.

 

  • References

  • Arrau C. M, Matte H. O, Palma J, Parada M, Toro O. G. Plasma antithrombin activity as aid in the diagnosis of pancreatic disease. Abstract in “Blood” 12: 106 1957;
    PubMedGoogle Scholar
  • Astrup T, Darling S. Antithrombin und Heparin. Naturwissenschaften 29: 300 1941;
    PubMedGoogle Scholar
  • Astrup T. et al. Measurement and properties of antithrombin. Acta physiol, scand. 04: 293 1942;
    CrossrefPubMedGoogle Scholar
  • Biggs R, Macfarlane R. G. Human blood coagulation and its disorders. Sec. Edition, Scientific Publications. Blackwell; Oxford: 1957
    Google Scholar
  • Burstein M, Guinand A. Héparine et consommation de l’antithrombine. Arch. int. Pharmacodyn. 104: 435 1955;
    PubMedGoogle Scholar
  • Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta haemat. (Basel) 17: 237 1957;
    CrossrefPubMedGoogle Scholar
  • Cullen G, van Slijke D. Determination of the fibrin, globulin and albumin nitrogen of blood-plasma. J. biol. Chem. 41: 587 1920;
    PubMedGoogle Scholar
  • Gerendas M. Inactivation of thrombin. Nature 157: 837 1946a
    PubMedGoogle Scholar
  • Gerendas M. Inactivation and stabilization of thrombin. Hung. Acta physiol. 01: 97 1946b
    PubMedGoogle Scholar
  • Greep J. M. Antithrombine en aandoeningen van het pancreas. (Antithrombin and diseases of the pancreas). Thesis; Utrecht: 1958
    Google Scholar
  • Grüning W. Zur Frage der chemischen Natur des Antithrombins. Pflügers Arch. ges. Physiol. 247: 292 1944;
    PubMedGoogle Scholar
  • Grüning W, Born H. Die klinische Bedeutung des Antithrombins. Langenbecks Archiv klin. Chir. 275: 556 1953;
    PubMedGoogle Scholar
  • Howell W. H. The condition of the blood in hemophilia, thrombosis and purpura. Arch. intern. Med. 13: 76 1914;
    PubMedGoogle Scholar
  • Hurn M, Barker N. W, Mann F. D. Variations in prothrombin and antithrombin in patients with thrombosing tendencies. Amer. J. clin. Path. 17: 709 1947a
    PubMedGoogle Scholar
  • Hurn M. et al. Variations in prothrombin and antithrombin following the administration of dicumarol. Amer. J. clin. Path. 17: 712 1947b
    PubMedGoogle Scholar
  • Imdahl H, Egli H, Kesseler K, Hennrich G. Über den Wert gerinnungsphysiologischer Untersuchungen bei Erkrankungen der Leber und des Gallengangssystems in der Chirurgie. Ärztl. Wschr. 12: 22 1957;
    PubMedGoogle Scholar
  • Innerfield I, Angrist A, Benjamin J. W. The antithrombin titer in acute pancreatitis. Bull. N.Y. Acad. Med. 27: 399 1951a
    PubMedGoogle Scholar
  • Innerfield I. et al. The antithrombin titer in cystic fibrosis of the pancreas. J. Pediat. 39: 287 1951b
    PubMedGoogle Scholar
  • Innerfield I. et al. Plasma antithrombin patterns in disturbances of the pancreas. Gastroenterology 19: 843 1951c
    PubMedGoogle Scholar
  • Innerfield I. Acute pancreatitis: the antithrombin titer as an aid in diagnosis and prognosis. N.Y. St. J. Med. II: 2239 1952;
    PubMedGoogle Scholar
  • Innerfield I, Angrist A, Benjamin J. W. Studies on trypsin. Gastroenterology 20: 630 1952a
    PubMedGoogle Scholar
  • Innerfield I. et al. Antithrombin titer in acute pancreatitis. Amer. J. Med. 12: 24 1952b
    PubMedGoogle Scholar
  • Innerfield I. et al. The antithrombin titer in pancreatic cyst. Amer. J. Surg. 83: 538 1952c
    PubMedGoogle Scholar
  • Innerfield I, Angrist A, Boyd L. J. Plasma antithrombin titer in incipient and advanced liver failure. Gastroenterology 20: 417 1952;
    PubMedGoogle Scholar
  • Innerfield I, Angrist A. The plasma antithrombin determination: a new test for cancer of the pancreas associated with jaundice. Amer. J. med. Sei. 223: 442 1952d
    PubMedGoogle Scholar
  • Jürgens J. Neue Bestimmungsmethoden und Bedeutung der Antithrombine für die Klinik. Klin. Wschr. 35: 303 1957;
    CrossrefPubMedGoogle Scholar
  • Kendall M. G. Rank Correlation Methods. 2nd ed.. Ch Griffin; London: 1955
    Google Scholar
  • Lyttleton J. W. The antithrombin activity of human plasma. Biochem. J. 58: 8 1954b
    PubMedGoogle Scholar
  • Lyttleton J. W. Biophysical studies on thrombin and antithrombin and the kinetics of their reaction. Thesis; London: 1954c..
    Google Scholar
  • MacFarlane J. C. W. Serum-antithrombin level in fibrocystic disease of the pancreas. Lancet II: 311 1952;
    PubMedGoogle Scholar
  • Marbet R, Winterstein A. Das Antithrombin. Studie, Hoffmann-La Roche. 1956
    PubMedGoogle Scholar
  • Marx R. Ärztl. Forschung 06: 136 1952;
    PubMedGoogle Scholar
  • Mosely V, Seymour W, Pappas A. Some observations on the plasma antithrombin test as a diagnostic aid. Sth. Med. J. (Bgham, Ala) 47: 476 1954;
    CrossrefPubMedGoogle Scholar
  • Neumayr A, Parzer O. Die klinische Bedeutung des Antithrombintests. Dtsch. med. Wschr. 81: 161 1956;
    Article in Thieme ConnectPubMedGoogle Scholar
  • Owen C. A, Bollman J. H. Serum and plasma antithrombin. Proc. Soc. exp. Biol. (N.Y) 67: 367 1948;
    CrossrefPubMedGoogle Scholar
  • Quick A. J. The normal antithrombin of the blood and its relations to heparin. Amer. J. Physiol. 123: 712 1938;
    PubMedGoogle Scholar
  • Quick A. J. Hemorrhagic Diseases. Lea and Febiger; Philadelphia: 1957
    Google Scholar
  • Rieben W. K. Simultaneous determination of prothrombin and antithrombin activity of blood plasma by two-stage method. Sang. 21: 493 1950;
    PubMedGoogle Scholar
  • Seegers W. H. Discussion: New Clotting factors — Blood clotting and allied problems. 5th conference; Josiah Macy Foundation N.Y: 132 1952a
    Google Scholar
  • Seegers W. H, Miller K. D, Andrews E. B, Murphy R. C. Fundamental interactions and effect of storage, ether, adsorbants and blood clotting on plasma antithrombin activity. Amer. J. Physiol. 169: 700 1952;
    PubMedGoogle Scholar
  • Sokal G. Die Bestimmung der Antithrombin-Aktivitäten des Plasmas. Acta haemat. (Basel) 14: 34 1955;
    CrossrefPubMedGoogle Scholar
  • Verstraete M, Vermylen M. Antithrombin I activity. Its interference with the estimation of antithrombin II activity in certain thrombin inhibitor determinations. Thromb. Diath. haem. 03: 640 1959;
    PubMedGoogle Scholar
  • Walpot L. De antithrombineproef bij acute pancreatitis. Ned. T. Geneesk. 102: 811 1958;
    PubMedGoogle Scholar
  • Waugh D. F, Fitzgerald M. A. Quantitative aspects of antithrombin and heparin in plasma. Amer. J. Physiol. 184: 627 1956;
    PubMedGoogle Scholar
  • Wilson S. J. Quantitative studies on antithrombin. Proc. Soc. exp. Biol. (N. Y) 43: 676 1940;
    CrossrefPubMedGoogle Scholar
  • Wilson S. J. Quantitative studies on antithrombin. Arch. intern. Med. 69: 647 1942;
    CrossrefPubMedGoogle Scholar
  • Witte S, Dirnberger P. Eine Methode zur isolierten Bestimmung von Thrombininhibitor und Antithrombin. Klin. Wschr. 31 II, 598 1953a
    PubMedGoogle Scholar
  • Witte S. et al. Die getrennte Bestimmung von Thrombininhibitor und Antithrombin. Schweiz, med. Wschr. 84: 800 1954;
    PubMedGoogle Scholar
  • Zürn H. Die Bedeutung der Antithrombinbestimmung für die Beurteilung von Erkrankungen der Gallenwege, der Leber und des Pankreas. Z. ärztl. Fortbild. 50: 727 1956;
    PubMedGoogle Scholar